Terminated NA INTERVENTIONAL 1-arm NCT03278236

Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? (RESHAPE2)

Sponsor: Salk Institute for Biological Studies

Conditions Insulin Resistance Type2 Diabetes

Interventions TRF

Updated 5 times since 2017 Last updated: May 23, 2018 Started: Sep 21, 2017 Primary completion: Dec 1, 2017 Completion: Dec 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient funding to complete pilot.

Other Insulin Resistance trials with similar outcome

Browse all Insulin Resistance trials

A NA clinical study on Insulin Resistance and Type2 Diabetes, this trial is terminated or withdrawn. The trial is conducted by Salk Institute for Biological Studies and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

Status: Not Yet Recruiting → Terminated
Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Salk Institute for Biological Studies
University of Adelaide

Data source: University of Adelaide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Adelaide, Australia